Evidence map›Paper›PMID 38476003›Full record

ArticleChronic respiratory disease

The Fagerström Test for Nicotine Dependence, as a prognostic factor, in current smokers with and without COPD: A cross-sectional study in northern Greece.

Efthymia Papadopoulou, Anna-Bettina Haidich, Alexander Mathioudakis, Drosos Tsavlis, Konstantina Papadopoulou, Rena Oikonomidou, Panagiotis Bogiatzidis, Stavros Tryfon

Open access · goldAbstract read
In one paragraph

Article in Chronic respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Efthymia PapadopoulouPulmonology Department, General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece.ORCID 0000-0002-2415-0842
Anna-Bettina HaidichLaboratory of Hygiene, Social & Preventive Medicine and Medical Statistics, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Alexander MathioudakisDivision of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester; North West Lung Centre, Wythenshawe Hospital, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Drosos TsavlisLaboratory of Experimental Physiology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantina PapadopoulouInternal Medicine Department, General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece.
Rena OikonomidouEvosmos Primary Healthcare Center, Thessaloniki, Greece.
Panagiotis BogiatzidisSchool of Health Sciences, University of Western Macedonia, Kozani, Greece.
Stavros TryfonPulmonology Department, General Hospital of Thessaloniki "G. Papanikolaou", Thessaloniki, Greece.ORCID 0000-0001-5102-0480
G. Papanikolaou General Hospital · GRAristotle University of Thessaloniki · GRManchester Academic Health Science Centre · GBUniversity of Western Macedonia · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmoking poses the most common risk factor for chronic obstructive pulmonary disease (COPD) and aggravates disease progression. Tobacco dependence inhibits smoking cessation and may affect smoking patterns that increase tobacco exposure and predispose to lung function decline. AIMS AND

objectivesWe aimed to assess tobacco dependence in current smokers with and without COPD and evaluate its role in disease development.

methodThis cross-sectional study was conducted in Greek rural areas. Current smokers completed the Fagerström Test for Nicotine Dependence and were classified into COPD and non-COPD groups based on spirometry parameters.

resultsAmong current smokers, 288 participants comprised the non-COPD and 71 the COPD group. Both presented moderate tobacco dependence, but smokers with COPD started to smoke earlier in the morning. Multiple logistic regression analysis revealed higher COPD prevalence in smokers with higher scores in the Fagerström test (odds ratio OR = 1.12, 95% confidence interval [1.01 - 1.24]) and older age (OR = 1.06 [1.03 - 1.09]), independently of pack-years smoking index. Multiple linear regression analysis in smokers with COPD showed that the forced expiratory volume in the 1st second decreased by 2.3% of the predicted value for each point increase in the Fagerström Test and 0.59% for each year of age, independently of participants' sex and pack-years smoking index.

conclusionThe Fagerström score appears to indicate a higher probability for COPD and lung function deterioration when assessed along with age in current smokers. Smoking cessation support programs are fundamental to COPD prevention and management.

Indexed as

Pulmonary Disease, Chronic ObstructiveTobacco Use DisorderCross-Sectional StudiesGreeceHumansPrognosisSmokerschronic obstructive lung diseaseFagerström testrural populationsmokersTobacco dependence

Identifiers

PMID38476003
PMCPMC10935750
OpenAlexW4392753676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.